Compare NRXS & NNOX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NRXS | NNOX |
|---|---|---|
| Founded | 2011 | 2011 |
| Country | United States | Israel |
| Employees | N/A | 197 |
| Industry | | Medical Electronics |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 78.9M | 69.6M |
| IPO Year | 2023 | 2019 |
| Metric | NRXS | NNOX |
|---|---|---|
| Price | $6.25 | $0.87 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $13.00 | $5.00 |
| AVG Volume (30 Days) | 93.5K | ★ 1.1M |
| Earning Date | 05-12-2026 | 04-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 22.13 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $3,569,282.00 | N/A |
| Revenue This Year | $172.91 | $147.55 |
| Revenue Next Year | $115.71 | $81.13 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 32.89 | N/A |
| 52 Week Low | $2.21 | $0.73 |
| 52 Week High | $9.33 | $4.71 |
| Indicator | NRXS | NNOX |
|---|---|---|
| Relative Strength Index (RSI) | 40.92 | 38.97 |
| Support Level | $5.59 | $0.85 |
| Resistance Level | $7.54 | $1.16 |
| Average True Range (ATR) | 0.42 | 0.08 |
| MACD | -0.02 | 0.00 |
| Stochastic Oscillator | 42.11 | 7.50 |
Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).
Nano X Imaging Ltd is focused on driving the world's transition to preventive health care by delivering an integrated, end-to-end medical imaging and healthcare services platform. The group combines affordable imaging hardware, progressive AI-based solutions, cloud-based software, access to remote radiology, health IT solutions, and a marketplace to enable earlier detection, improved clinical efficiency, and broader access to care. The three segments are composed of the Nanox.ARC segment, the AI and software solutions segment, and the Radiology services segment. Key revenue is generated from Radiology Services.